Meeting
2014 ASCO Annual Meeting
Expression profile of angiogenic factors in paired initial and recurrent glioblastoma.
Authors
Emeline Tabouret
Aix-Marseille University, AP-HM, Service de Neuro-Oncologie, CHU Timone, Marseille, France
Emeline Tabouret , Aurelie Tchoghandjian , Emilie Denicolai , Christine Delfino , Philippe Metellus , Laetitia Padovani , Isabelle Nanni , Maryline Barrie , Celine Boucard , L'houcine Ouafik , Dominique Figarella-Branger , Olivier L. Chinot
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 2060)
DOI
10.1200/jco.2014.32.15_suppl.2060
Abstract #
2060
Poster Bd #
25
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Association of SDF1 inhibition with local control and relative cerebral blood volume of glioblastoma.
First Author: Reena Parada Thomas
Poster
2016 ASCO Annual Meeting
A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).
First Author: Reena Parada Thomas
Poster
2013 ASCO Annual Meeting
Use of axitinib, a new-generation tyrosine kinase inhibitor, to decrease glioblastoma growth despite primary resistance to the VEGF-antibody bevacizumab.
First Author: Tobias Kratzsch
Poster
2015 ASCO Annual Meeting
Candidate biomarker analyses in gastric or gastro-esophageal junction carcinoma: REGARD trial of single-agent ramucirumab (RAM) vs. placebo (PL).
First Author: Charles S. Fuchs